West Coast University Module 4 Medicare and Medicaid Programs Discussion
Evaluation Topic: Effectiveness of Tobacco Control Policies on Reducing Smoking Rates
Brief Description: The evaluation topic focuses on assessing the effectiveness of tobacco control policies in reducing smoking rates. Tobacco use is a significant public health concern associated with various diseases and health disparities. This evaluation examines the impact of community, state, and federal policies, such as tobacco taxes, smoking bans in public places, and anti-smoking campaigns, on decreasing smoking prevalence.
Criteria for Evaluation:
- Smoking Prevalence: The primary criterion is the reduction in smoking prevalence over time. This can be measured through surveys, such as the National Health Interview Survey (NHIS), which assesses smoking behavior among various demographic groups.
- Health Outcomes: Another criterion is improvements in health outcomes associated with smoking, such as reductions in lung diseases, cardiovascular diseases, and cancer. This can be assessed using data from hospitals, healthcare providers, and mortality statistics.
- Policy Compliance: Evaluators consider the level of compliance with tobacco control policies, as higher compliance typically leads to better outcomes. Compliance can be measured through monitoring the enforcement of smoking bans and adherence to regulations.
- Economic Impact: The evaluation also examines the economic impact of the policies, including reductions in healthcare costs related to smoking-related illnesses and increased revenue from tobacco taxes.
Social Determinants Impact: Social determinants of health play a crucial role in the effectiveness of tobacco control policies. These determinants, such as income, education, and access to healthcare, can influence smoking behaviors and policy outcomes.
- Income and Education: People with lower socioeconomic status are often more susceptible to smoking due to factors like stress, limited access to education, and targeted marketing by tobacco companies. Policies must consider these disparities to ensure equitable reductions in smoking rates.
- Access to Healthcare: Individuals with limited access to healthcare may face challenges in accessing smoking cessation resources, such as counseling and medications. Effective policies should address barriers to accessing these services.
- Cultural and Social Norms: Cultural norms and social pressures can influence smoking behavior. Policies should be culturally sensitive and considerate of social influences to effectively target specific populations.
- Advertising and Marketing: Tobacco companies often target vulnerable populations with aggressive marketing strategies. Evaluations should assess the impact of policies on reducing the influence of these marketing tactics.
References:
- DOI: 10.2105/AJPH.93.8.1261 Title: Why Don’t We See More Translation of Health Promotion Research to Practice? Rethinking the Efficacy-to-Effectiveness Transition
- DOI: 10.1007/s40615-016-0302-4 Title: Leading by Success: Impact of a Clinical and Translational Research Infrastructure Program to Address Health Inequities
- DOI: https://doi.org/10.1016/j.outlook.2018.05.003 Title: Omics research ethics considerations
- National Institute on Drug Abuse (NIDA). (2021). Tobacco. URL: https://www.drugabuse.gov/drug-topics/tobacco
- Centers for Disease Control and Prevention (CDC). (2021). Smoking & Tobacco Use. URL: https://www.cdc.gov/tobacco/index.htm
QUESTION
Description
Select an existing healthcare program or policy evaluation or choose one of interest to you.
Review community, state, or federal policy evaluation and reflect on the criteria used to measure the effectiveness of the program or policy described.
Post an evaluation topic and a brief description of the evaluation. Discuss how social determinants impact this issue.
- Course References Uese 2 of them only and 2 outside references that have DOI
DOI: 10.2105/AJPH.93.8.1261 Why Don’t We See More Translation of Health Promotion Research to Practice? Rethinking the Efficacy-to-Effectiveness Transition
DOI: 10.1007/s40615-016-0302-4 Leading by Success: Impact of a Clinical and Translational Research Infrastructure Program to Address Health Inequities
DOI: https://doi.org/10.1016/j.outlook.2018.05.003 Omics research ethics considerations